1. Introduction {#sec1-molecules-23-01539}
===============

*Mahonia imbricata* Ying *et* Boufford, as one of the endemics of seed plants in China, is a perennial shrub of the family Berberidaceae, distributed only in Guizhou and Yunan provinces of Southwest China \[[@B1-molecules-23-01539]\]. Plants of the genus *Mahonia* have long been used as a traditional medicine to treat tuberculosis, periodontitis, dysentery, pharyngolaryngitis, eczema, and wounds \[[@B2-molecules-23-01539]\]. Previous chemical investigations on this genus have involved a series of chemical constituents. Among these constituents, alkaloids are principal constituents of the genus *Mahonia* \[[@B3-molecules-23-01539],[@B4-molecules-23-01539],[@B5-molecules-23-01539]\]. As part of an ongoing research program to isolate and determine structures of secondary metabolites from medicinal endemic plants of southwestern China \[[@B6-molecules-23-01539],[@B7-molecules-23-01539]\], we performed a phytochemical study on *M. imbricate.* As a result, a novel isoquinoline alkaloid, possessing a rare benzotropolone substituent, was isolated ([Figure 1](#molecules-23-01539-f001){ref-type="fig"}). Its structure was established by means of spectroscopic analysis including one- and two-dimensional NMR spectroscopy. Moreover, the hypothetical biosynthetic route was proposed. Mahimbrine A was tested against four gram-positive bacterial strains and four gram-negative bacteria.

2. Results and Discussion {#sec2-molecules-23-01539}
=========================

2.1. Structure Elucidation of Mahimbrine A {#sec2dot1-molecules-23-01539}
------------------------------------------

Mahimbrine A was obtained as a brown gum. Its molecular formula was established as C~24~H~23~NO~5~ on the basis of the HR-ESI-MS (\[M + H\]^+^ at *m*/*z* 406.1632, calcd. 406.1649 and \[2M + H\]^+^ at *m*/*z* 811.3226, calcd. 811.3225), which requires 14 degrees of unsaturation. The IR absorptions at 3434 and 1633 cm^−1^ suggested the presence of hydroxyl and carbonyl groups in the molecule. UV absorptions at λ~max~ 230 and 288 nm deduced the presence of an α, β-unsaturated carbonyl moiety \[[@B8-molecules-23-01539]\]. The ^1^H, ^13^C NMR and HSQC spectra of mahimbrine A ([Table 1](#molecules-23-01539-t001){ref-type="table"}) showed 24 carbon resonances due to a methine at δ~H~ 2.91 (2H, m), δ~C~ 25.8; four methoxyl groups at δ~H~ 3.60 (3H, s), 3.93 (6H, s), 3.94 (3H, s), δ~C~ 56.2, 56.2, 56.2, 61.8; a methine at δ~H~ 3.90 (1H, m), 4.03 (1H, m), δ~C~ 47.9; a 1,2,3,4-tetrasubstituted phenyl ring moiety at δ~H~ 7.04 (1H, d, *J* = 9.1 Hz), 7.28 (1H, d, *J* = 9.1 Hz), δ~C~ 153.7, 148.4, 1131.5, 129.2, 128.8, 114.5; a 1,2,4,5-tetrasubstituted phenyl ring moiety at δ~H~ 6.57 (1H, s), 6.78 (1H, s), δ~C~ 151.8, 147.9, 131.4, 121.9, 110.6, 110.6; a carbonyl at δ~C~ 188.4; and an unsaturated system at δ~H~ 8.20 (1H, d, *J* = 13.0 Hz), 6.87 (1H, dd, *J* = 13.0, 2.7 Hz), 6.74 (1H, d, *J* = 2.7 Hz), δ~C~ 168.4, 148.8, 134.9, 133.6, 133.5.

The obvious HMBC correlations ([Figure 2](#molecules-23-01539-f002){ref-type="fig"}) from H-3 to C-1, C-4a, H-4 to C-5, C-4a, C-8a, H-5 to C-4, C-7, C-8a, H-8 to C-1, C-4a, C-6, OCH~3~ to C-6 and OCH~3~ to C-7 evidenced the presence of a dihydroisoquinoline unit with two methoxyl groups located at C-6 and C-7, respectively. The HMBC correlations of H-9′ to C-7′ (δ~C~ 188.4), C-4′a, H-8′ to C-6′, C-9′a (δ~C~ 131.5), and H-6′ to C-4′a (δ~C~ 129.2), C-8′a, established the presence of a tropolone moiety, which was further verified by the vicinal coupling constants of H-8′/H-9′ (*J* = 13.0 Hz) \[[@B9-molecules-23-01539]\]. Moreover, the HMBC correlations of H-9′ to C-1′, C-4′a, H-4′ to C-2′, C-5′, C-9′a confirmed the tropolone moiety and 1,2,3,4-tetrasubstituted phenyl ring moiety connected via a bridged bond at C-4′a and C-9′a. Similarly, two methoxyl groups at C-1′ and C-2′ were also assigned. The HMBC correlations of H-6′ to C-1, C-4′a and H-4′ to C-5 indicated that the dihydroisoquinoline unit and benzotropolone unit were connected to each other by C-1 and C-5′. Thus, the final structure of this compound was determined and named mahimbrine A.

2.2. Plausible Biogenetic Pathway {#sec2dot2-molecules-23-01539}
---------------------------------

A plausible biogenetic pathway for mahimbrine A was postulated ([Scheme 1](#molecules-23-01539-sch001){ref-type="scheme"}). As a precursor, naphthylacetic acid and dopamine via condensation reaction to give an amide intermediate **1** \[[@B10-molecules-23-01539]\], which subsequently undergoes a Bischler-Napieralski reaction to generate intermediate **2** \[[@B11-molecules-23-01539]\]. Intermediate **2** is then oxidized to yield intermediate **3** \[[@B12-molecules-23-01539]\]. Intermediate **3** can spontaneously convert to its enol form. This enol intermediate then undergoes ring expansion rearrangement to give intermediate **4** \[[@B13-molecules-23-01539]\], which is finally methylated to get mahimbrine A.

2.3. Antimicrobial Activity {#sec2dot3-molecules-23-01539}
---------------------------

The antimicrobial activity of mahimbrine A was evaluated against four gram-positive bacterial strains *Staphylococcus aureus* ATCC 6538, *Micrococcus luteus* CMCC 28001, *Staphylococcus epidermidis* ATCC 12228, and *Bacillus subtilis* ATCC 21332; and four gram-negative bacteria *Pseudomonas aeruginosa* ATCC 27853, *Escherichia coli* ATCC 25922, *Salmonella typhimurium* ATCC 14028, and *Enterobacter aerogenes* ATCC 13048, by a microdilution titre technique; neither was active \[[@B14-molecules-23-01539]\]. Gentamicin and streptomycin were used as positive controls. Discs containing 10 μL DMSO solutions were used as a negative control. All tests were performed in triplicate.

3. Experimental Section {#sec3-molecules-23-01539}
=======================

3.1. General Procedures {#sec3dot1-molecules-23-01539}
-----------------------

UV spectra were recorded on a Perkin-Elmer Lambda 35 UV-VIS spectrophotometer (Perkin-Elmer, Waltham, MA, USA). IR spectra were measured on a PerkinElmer one FT-IR spectrometer (KBr) (Perkin-Elmer, Waltham, MA, USA). 1D and 2D-NMR spectra were recorded on a Bruker-Ascend-400 or an Agilent DD2400-MR instrument using TMS as the internal reference. HR-ESI-MS spectra were measured on a LTQ Orbitrap XL mass spectrometer (Thermo Scientific, Waltham, MA, USA). Column chromatography was performed using silica gel (300--400 mesh, Qingdao marine Chemical Ltd., Qingdao, China). Semi-preparative HPLC was performed on LC3000 system (Beijing ChuangXingTongHeng Science And Technology Co., Ltd., Beijing, China) equipped with an ODS column (5 μm, i.d. 10 mm × 250 mm, YMC). Original raw data of 1D, 2D NMR spectra and HR-ESI-MS of mahimbrine A are available in the [supplementary materials](#app1-molecules-23-01539){ref-type="app"}.

3.2. Plant Material {#sec3dot2-molecules-23-01539}
-------------------

The plant was collected from Loushanguan in Zunyi City, People's Republic of China, in October 2013, and identified as *Mahonia imbricata* by Prof. Jian-Wen Yang, Zunyi Medical University. A voucher specimen (20131020) was deposited with the Herbarium of the School of Pharmacy, Zunyi Medical University.

3.3. Extraction and Isolation {#sec3dot3-molecules-23-01539}
-----------------------------

The air-dried and finely ground stems of *Mahonia imbricata* (30 kg) were extracted with 90% ethanol for three times at room temperature (5 days each). The ethanol extract was evaporated under reduced pressure to get a crude extract (2 kg), which was further suspended in acidic water (pH 3--4) and then filtered to obtain the filtrate. The filtrate was alkalized to pH 9--10 and extracted successively with CHCl~3~ and n-BuOH (each 3 times), respectively. The CHCl~3~ extract was subjected to silica gel column chromatography (80 mm × 600 mm, 1400 g, 300--400 mesh), eluted with a gradient of CHCl~3~/MeOH (*v*/*v* = 100:1--1:100) to afford ten fractions (A--J). Fraction C was separated by Sephadex LH-20 column chromatography (CHCl~3~/MeOH = 1:1) and divided into 15 subfractionses (fraction A.1--A.15). Mahimbrine A (3.8 mg) was obtained from fraction A.6 by sempipreparative HPLC (MeOH/H~2~O = 55:45, flow rate 4 mL/min).

3.4. Spectral Data {#sec3dot4-molecules-23-01539}
------------------

Mahimbrine A: brown gum; UV (CH~3~OH): 230 (2.68), 288 (2.43); IR (KBr): 3434, 2920, 1633, 1590, 1512, 1384, 1292, 1026, 810; ^1^H and ^13^C NMR data, [Table 1](#molecules-23-01539-t001){ref-type="table"}. HR-ESI-MS: *m*/*z* 406.1632 \[M + H\]^+^, C~24~H~24~NO~5~^+^, calcd. 406.1649; *m*/*z* 811.3226 \[*2*M + H\]^+^, calcd. 811.3225.

4. Conclusions {#sec4-molecules-23-01539}
==============

In conclusion, mahimbrine A has been isolated from the endemic plant of *Mahonia imbricate* and its chemical structure has been elucidated. It displays an interesting structure with a dihydroisoquinoline moiety bound to a rare benzotropolone ring system. The structure of mahimbrine A was elucidated by HR-ESI-MS, 1D, 2D NMR and a biosynthetic pathway was proposed. Mahimbrine A did not show antimicrobial activity at the tested concentration of 1 mg/mL. The interesting structural architecture of this natural product might find further applications.
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###### 

^1^H and ^13^C NMR data for mahimbrine A (400/100 MHz, in CDCl~3~).

  Position    δ~H~            δ~C~    Position   δ~H~                   δ~C~
  ----------- --------------- ------- ---------- ---------------------- -------
  1                           168.4   1′                                148.4
  3           4.03, 3.90, m   47.9    2′                                153.7
  4           2.91, m         25.8    3′         7.04, d (9.1)          114.5
  4a                          131.4   4′         7.28, d (9.1)          128.8
  5           6.78, s         110.6   4′a                               129.2
  6                           151.8   5′                                148.8
  7                           147.9   6′         6.74, d (2.7)          133.5
  8           6.57, s         110.6   7′                                188.4
  8a                          121.9   8′         6.87, dd (13.0, 2.7)   134.9
  6-OCH~3~    3.94, s         56.2    9′         8.20, d (13.0)         133.6
  7-OCH~3~    3.60, s         56.2    9′a                               131.5
  1′-OCH~3~   3.93, s         61.8                                      
  2′-OCH~3~   3.93, s         56.2                                      
